Resultados de Búsqueda por Autor

1

artículo

The STOP Program: a Hybrid Smoking Prevention and Cessation Training for Cancer Care Providers in Colombia and Peru

Publicado por
Tami-Maury, I, Tundealao, S, Diaz, V, Ochoa, E, Garcia, E, Rincon, J, Noe-Díaz V, Castaneda, C, Acosta, J, Fernandez, M, Vidaurre, T, Crowley, J

Publicado 2023

Enlace

We designed and tested the feasibility of the Smoking Cessation Training Program for Oncology Practice (STOP), a hybrid (face-to-face plus web-based) educational intervention to enhance Spanish-speaking cancer care professionals’ (CCPs’) ability to provide brief smoking prevention and cessation counseling to cancer patients and survivors. Changes in the CCPs’ competencies (knowledge, attitude, self-efficacy, and practices toward smoking and smoking cessation services) were assessed post-training. Sixty CCPs from one major cancer center in Colombia (n = 30) and Peru (n = 30) were invited to participate in a 4-module hybrid training program on smoking prevention and cessation. Demographic and pre- and post-test evaluation data were collected. The training’s acceptability was measured after each module. Bivariate analysis was conducted using Wilcoxon signed-rank test to compare the ...

2

artículo

Diseño del estudio IBEAS: prevalencia de efectos adversos en hospitales de Latinoamérica

Publicado por
Aranaz Andres, J. M., Aibar Remón, Carlos, Limón Ramírez, R., Amarilla, A., Restrepo, F. R., Urroz, O., Sarabia, O., Inga, R., Santivañez, A., Gonseth García, J., Larizgoitia Jauregui, I., Agra Varela, Y., Terol García, E.

Publicado 2011

Enlace

Objetivos: Describir las características y metodología del estudio IBEAS: prevalencia de efectos adversos en hospitales de Latinoamérica, que persigue realizar una aproximación a la magnitud, trascendencia e impacto de los eventos adversos (EA); identificar áreas y problemas prioritarios de la seguridad del paciente; incrementar la masa crítica de profesionales involucrados en la seguridad del paciente e incorporar a la agenda de los países objetivos y actividades para mejorar la seguridad del paciente. Método: Estudio sobre la seguridad de los pacientes. Ámbito: 35 hospitales de 5 países: Argentina, Colombia, Costa Rica, México y Perú, a través del análisis de los efectos adversos identificados. Diseño de prevalencia utilizando la revisión de la historia clínica. Resultados: Se describen las implicaciones en el uso del diseño transversal en el estudio de EA, tanto en l...

3

artículo

Latin American Study of Hereditary Breast and Ovarian Cancer LACAM: A Genomic Epidemiology Approach

Publicado por
Oliver J., Quezada Urban R., Franco Cortés C.A., Díaz Velásquez C.E., Montealegre Paez A.L., Pacheco-Orozco R.A., Castro Rojas C., García-Robles R., López Rivera J.J., Gaitán Chaparro S., Gómez A.M., Suarez Obando F., Giraldo G., Maya M.I., Hurtado-Villa P., Sanchez A.I., Serrano N., Orduz Galvis A.I., Aruachan S., Nuñez Castillo J., Frecha C., Riggi C., Jauk F., Gómez García E.M., Carranza C.L., Zamora V., Torres Mejía G., Romieu I., Castañeda C.A., Castillo M., Gitler R., Antoniano A., Rojas Jiménez E., Romero Cruz L.E., Vallejo Lecuona F., Delgado Enciso I., Martínez Rizo A.B., Flores Carranza A., Benites Godinez V., Méndez Catalá C.F., Herrera L.A., Chirino Y.I., Terrazas L.I., Perdomo S., Vaca Paniagua F., LACAM Study

Publicado 2019

Enlace

Purpose: Hereditary Breast and Ovarian Cancer (HBOC) syndrome is responsible for ~5–10% of all diagnosed breast and ovarian cancers. Breast cancer is the most common malignancy and the leading cause of cancer-related mortality among women in Latin America (LA). The main objective of this study was to develop a comprehensive understanding of the genomic epidemiology of HBOC throughout the establishment of The Latin American consortium for HBOC-LACAM, consisting of specialists from 5 countries in LA and the description of the genomic results from the first phase of the study. Methods: We have recruited 403 individuals that fulfilled the criteria for HBOC from 11 health institutions of Argentina, Colombia, Guatemala, Mexico and Peru. A pilot cohort of 222 individuals was analyzed by NGS gene panels. One hundred forty-three genes were selected on the basis of their putative role in suscept...